Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preservative-free hydroxypropyl methylcellulose with dextran for dry eye after phacoemulsification in diabetic patients
TCTR20251003009Phase 2Recruiting
- Sponsor
- Thammasat University Hospital
- Start
- Jul 2025
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of Hydroxypropylmethylcellulose + dextran in dry eye syndrome (DED), sponsored by Thammasat University Hospital. Started Jul 2025; status: recruiting.
02
Drugs
Hydroxypropylmethylcellulose + dextran
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on TCTR20251003009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251003009.